Campbell & Co Investment Adviser’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,334
Closed -$211K 595
2018
Q2
$211K Buy
+4,334
New +$224K 0.16% 295
2018
Q1
Sell
-4,684
Closed -$233K 595
2017
Q4
$233K Buy
+4,684
New +$233K 0.17% 275
2015
Q2
Sell
-3,300
Closed -$242K 298
2015
Q1
$242K Buy
+3,300
New +$234K 0.15% 171
2014
Q4
Sell
-44,918
Closed -$3.11M 331
2014
Q3
$3.11M Buy
44,918
+35,418
+373% +$2.49M 1.59% 8
2014
Q2
$590K Buy
+9,500
New +$557K 0.24% 113
2013
Q4
Sell
-5,046
Closed -$235K 387
2013
Q3
$235K Sell
5,046
-20,329
-80% -$973K 0.05% 214
2013
Q2
$1.24M Buy
+25,375
New +$1.22M 0.24% 124

Other funds holding LPNT

Campbell & Co Investment Adviser's LPNT Position: Q3 2018 in Review

Campbell & Co Investment Adviser sold out of LifePoint Health, Inc. (LPNT) in Q3 2018, closing a stake of 4,334 shares — an estimated $211K sold.

Campbell & Co Investment Adviser first reported a position in LPNT in Q2 2013 and held it in 7 quarters. The position peaked at $3.11M in Q3 2014. 223 funds tracked by Wall St. Rank hold LPNT as of Q3 2018.

  • Campbell & Co Investment Adviser reported no remaining LifePoint Health, Inc. position as of Q3 2018 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 4,334 LifePoint Health, Inc. shares in Q3 2018, an estimated $211K.
  • Campbell & Co Investment Adviser first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 7 quarters.
  • Campbell & Co Investment Adviser's LifePoint Health, Inc. position peaked at $3.11M in Q3 2014.
  • 223 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q3 2018.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2018, filed 8 Nov 2018.